Arachidonic acid is the omega-6 fatty acid everyone tells you to avoid — but for muscle hypertrophy, it may be the most underappreciated lipid in existence. ARA is the direct precursor to PGF2α (prostaglandin F2-alpha), which is the primary signaling molecule that initiates muscle protein synthesis after resistance training. A 2016 study found 1,500mg/day ARA increased lean body mass by 2.9 lb vs placebo over 8 weeks in trained men. The controversy: ARA also produces pro-inflammatory prostaglandins (PGE2) and leukotrienes — the SAME molecules that drive chronic inflammation. Context matters: exercise-induced inflammation is anabolic, chronic inflammation is catabolic.
ARA is released from cell membrane phospholipids by phospholipase A2 during mechanical stress (exercise). Once freed, COX-2 converts ARA to PGF2α and PGE2. PGF2α activates FP receptors on muscle cells → calcium-dependent signaling → muscle protein synthesis (mTOR-independent pathway). This is the LOCAL inflammatory response that drives muscle adaptation. The concern about systemic inflammation is largely unfounded in exercising individuals because the prostaglandins are produced locally, act in paracrine fashion, and are rapidly metabolized. The key insight: NSAIDs blunt this pathway, which is why chronic NSAID use reduces muscle gains.
Reviewed by the Scan Dose Research Team and Clinical Advisory Board | Last updated:
Not medical advice. Based on published clinical research and systematic reviews.